Evidence map›Paper›PMID 42793040›Full record

ArticleGenes2026

The Significance of Somatic Variants Involved in the Development of Pancreatic Cancer in Patients with HBOC-Associated Germline Variants.

Koki Uchiyama, Hinano Nishikubo, Tomoya Sano, Yukina Furukawa, Dongheng Ma, Daiki Imanishi, Takemi Ishidate, Hongdong Gao, Canfeng Fan, Masakazu Yashiro

Abstract read
In one paragraph

Article in Genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Koki UchiyamaMolecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan.ORCID 0009-0006-8548-5132
Hinano NishikuboMolecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan.ORCID 0009-0004-7058-079X
Tomoya SanoMolecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan.
Yukina FurukawaMolecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan.
Dongheng MaMolecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan.ORCID 0009-0000-7620-0269
Daiki ImanishiMolecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan.
Takemi IshidateMolecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan.
Hongdong GaoMolecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan.
Canfeng FanMolecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan.
Masakazu YashiroMolecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan.ORCID 0000-0001-5743-7228

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHereditary cancer predisposition syndromes show a high risk of cancer development with germline pathogenic variants. Organ-specific surveillance has been recommended according to the causative gene. However, even among carriers of the same germline variants, developing cancer types are not always uniform. Tumor-normal paired comprehensive genomic profiling (CGP) enables the simultaneous assessment of germline and somatic variants in same patient. Correlations between germline variants and cancer types have been reported; however, the significance of combinations of a germline variant and somatic variants remain unclear in the development of cancer types.

methodsIn this study, we analyzed the correlation between pancreatic cancer and somatic variant patterns in patients with hereditary cancer predisposition syndrome, especially in patients with germline variants on

resultsHere, we show the characteristic pancreatic cancer patterns according to co-existing somatic variants in patients with germline pathogenic variants. The tumor-normal paired genetic data from 18,732 patients who underwent tumor-normal paired CGP were analyzed, including 853 germline-positive patients registered in a Japanese database. The combination of the somatic

conclusionsThese findings suggest that pancreatic cancer of hereditary cancer syndromes might be associated with co-existing somatic

Indexed as

Germ-Line MutationHereditary Breast and Ovarian Cancer SyndromePancreatic NeoplasmsAdultAgedAtaxia Telangiectasia Mutated ProteinsBRCA1 ProteinBRCA2 ProteinFemaleGenetic Predisposition to DiseaseHumansMaleMiddle AgedProto-Oncogene Proteins p21(ras)Tumor Suppressor Protein p53Ataxia Telangiectasia Mutated ProteinsATM protein, humanBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, humanKRAS protein, humanProto-Oncogene Proteins p21(ras)TP53 protein, humanTumor Suppressor Protein p53ATMBRCA1BRCA2C-CATgermline variantHBOChereditary cancerKRASpancreatic cancersomatic variantTP53

Identifiers

PMID42793040
PMCPMC13606352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.